Wealth Enhancement Advisory Services
AUPH icon

Wealth Enhancement Advisory Services’s Aurinia Pharmaceuticals AUPH Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Buy
24,382
+3,783
+18% +$60.4K ﹤0.01% 2954
2026
Q1 		$322K Buy
20,599
+6,347
+45% +$92.8K ﹤0.01% 2702
2025
Q4 		$220K Buy
14,252
+2,834
+25% +$40.2K ﹤0.01% 3198
2025
Q3 		$134K Sell
11,418
-1,571
-12% -$17.2K ﹤0.01% 3264
2025
Q2 		$98.6K Buy
12,989
+2,238
+21% +$17.9K ﹤0.01% 3138
2025
Q1 		$86.4K Buy
+10,751
New +$87.1K ﹤0.01% 2788

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's AUPH Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Aurinia Pharmaceuticals (AUPH) stake by 18% in Q2 2026, buying an estimated $60.4K and bringing the position to 24,382 shares worth $385K. The position accounts for ﹤0.01% of the portfolio, ranked #2954.

Wealth Enhancement Advisory Services first reported a position in AUPH in Q1 2025 and has held it in 6 quarters since. 281 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Wealth Enhancement Advisory Services held 24,382 shares of Aurinia Pharmaceuticals worth $385K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 3,783 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $60.4K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2954 holding.
  • Wealth Enhancement Advisory Services first reported a position in Aurinia Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 281 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.